VJOncology is committed to improving our service to you

ASCO 2019 | Lung Cancer: the impact of immunotherapy

VJOncology is committed to improving our service to you

Roy Herbst

Roy Herbst, MD, PhD, FACP, FASCO, of Yale University, New Haven, CT, explains the impact of immunotherapy in the treatment of lung cancer at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter